Market Exclusive

Analyst Activity – Royal Bank Of Canada Reiterates Neutral on Fresenius Medical Care Corporation (NYSE:FMS)

Analyst Ratings For Fresenius Medical Care Corporation (NYSE:FMS)

Today, Royal Bank Of Canada reiterated its Neutral rating on Fresenius Medical Care Corporation (NYSE:FMS).

There are 4 hold ratings, 7 buy ratings on the stock.

The current consensus rating on Fresenius Medical Care Corporation (NYSE:FMS) is Buy (Score: 2.64) with a consensus target price of $46.00 per share, a potential 2.81% downside.

Some recent analyst ratings include

Dividend information for Fresenius Medical Care Corporation (NYSE:FMS)

Fresenius Medical Care Corporation (NYSE:FMS) pays an annual dividend of Community Ranking: with a yield of 0.78% and an average dividend growth of -2.10% based on a 3 Year Average.

Dividend History for Fresenius Medical Care Corporation (NYSE:FMS)


Recent Trading Activity for Fresenius Medical Care Corporation (NYSE:FMS)
Shares of Fresenius Medical Care Corporation closed the previous trading session at 47.33 up +0.25 0.53% with 141,734 shares trading hands.

Exit mobile version